Myelinoclastic diffuse sclerosis (Schilder’s disease) is immunologically distinct from multiple sclerosis: results from retrospective analysis of 92 lumbar punctures
Myelinoclastic diffuse sclerosis (MDS; also termed Schilder’s disease) is a rare inflammatory demyelinating disorder of the central nervous system characterised by demyelination of vast areas of the white matter. It is unclear whether MDS is a variant of multiple sclerosis (MS) or a disease entity i...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
28 February 2019
|
| In: |
Journal of neuroinflammation
Year: 2019, Jahrgang: 16 |
| ISSN: | 1742-2094 |
| DOI: | 10.1186/s12974-019-1425-4 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/s12974-019-1425-4 Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12974-019-1425-4 
|
| Verfasserangaben: | S. Jarius, J. Haas, F. Paul and B. Wildemann |
| Zusammenfassung: | Myelinoclastic diffuse sclerosis (MDS; also termed Schilder’s disease) is a rare inflammatory demyelinating disorder of the central nervous system characterised by demyelination of vast areas of the white matter. It is unclear whether MDS is a variant of multiple sclerosis (MS) or a disease entity in its own right. |
|---|---|
| Beschreibung: | Gesehen am 07.03.2019 |
| Beschreibung: | Online Resource |
| ISSN: | 1742-2094 |
| DOI: | 10.1186/s12974-019-1425-4 |